Value Game Icon

Value Game

High-tech, luxury goods, and pharmaceutical companies in the Value Game take a value-based approach to pricing. The quality of their offering means they face less competition, while the offering’s broad appeal leaves customers with little buying power. That gives them the leeway to shape demand by aligning their prices with customer value and defending that value with obsessive marketing.

Your path to growth depends on:

  • Deciding how much value to share with your customers: This is the essence of pricing strategy. Will you use your leeway to penetrate the market or earn higher margins?
  • Establishing a pricing model that scales with value: A razor‐and‐blades model, for example, can help to encourage repeated follow‐on purchases. In some cases, pricing per outcome or performance can also make sense.
  • Mitigating potential value erosion: Investments in innovation and branding ensure continuous improvement and protect the value proposition.

That last point indicates how Value Game players can lose their edge. That happens when they let competitors catch up (less innovation), when they lose control of their narrative (less marketing) or when they let their prices get misaligned with value.

More Value Game Insights


Winning the Value Game

When Apple launched its Vision Pro headset in June, the price point of $3,499 grabbed many of the headlines and sparked countless discussions. Was the price too high? Was it…
—> Read more

The Seven Games of Pricing Strategy

What is your pricing strategy? BBusiness leaders often answer that question by citing a method such as “charging what the market will bear” or applying a markup to costs. Some…
—> Read more

Japan’s Tourist Surge: Can Differentiated Pricing Help Control the Overflow?

Japan has too many tourists. Is differentiated pricing the solution?This article reports that Japan attracted an “unprecedented” 25 million tourists in 2023, as travelers took advantage of a sharp decline…
—> Read more

The problem with US health care is math, not greed

The high cost of US health care made headlines again this week when the Biden Administration submitted its initial offers in the negotiations for Medicare drug prices. But maybe the…
—> Read more

Inflation higher than expected

Inflation in the US was higher than expected in January at 3.1%, but as always, such numbers come with caveats. First, as I mentioned in the last Game Changer newsletter…
—> Read more

How Nvidia changed its pricing game

How Nvidia’s shift from the Power Game to the Value Game sparked a nearly $2 trillion market capitalization 📈   In this edition of the Newsletter, Arnab Sinha and I…
—> Read more

Users or usage: what drives AI value?

The GenAI market is rapidly evolving, presenting unique challenges and opportunities for providers, especially in the realm of pricing strategies. This week, we dive deep into the intricacies of GenAI…
—> Read more

Can different pricing models address obesity problem?

Honored to be featured in a recent piece by AJMC, discussing innovative pricing models to tackle America’s obesity crisis. The article explores the potential of outcome-based and models to make…
—> Read more

Can pricing end the obesity crisis

Can pricing end the obesity crisis?   In this special edition of the Game Changer Newsletter, Arnab Sinha and I delve into an urgent global health crisis: obesity. We argue…
—> Read more

Apple Vision Pro adoption

Apple Vision Pro, the $3,499 headset launched in February, may not have a killer app for consumers yet, but it has apparently seen a high level of adoption among businesses….
—> Read more

From Value Game to Choice Game

In the latest edition of the Game Changer Expert Interview Series, BCG’s Joel S. Weitzman takes a closer look at transitioning from the Value Game to the Choice Game. Watch…
—> Read more

White House plan to eliminate Hep C

Thanks Dave for sharing. It has been a labor of love and persistence and you have been at the center of it. Great to see a comprehensive plan proposed at…
—> Read more